Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALBIS for gastroduodenal protection in DAPT patients post-PCI
NCT02175186Phase 4Completed
- Start
- Jan 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Albis in gastritis, gastroduodenal ulcer. Started Jan 2015; status: completed.
02
Drugs
Albis
03
Conditions
gastritisgastroduodenal ulcer
Beyond the preview
Go deeper on NCT02175186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02175186.